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ABSTRACT 
Background: Enteropathogenic Escherichia coli (EPEC) are pathogenic microorganisms causing inflammation 
and imbalanced gut microflora that may result in diarrhea. Pediococcus pentosaceus (P. pentosaceus) isolated 
from “dadih” (milk curd) are used as probiotics containing lactic acid bacteria (LAB), which are useful to 
improve the balance of intestinal microflora and inhibit the growth of pathogenic microorganisms. This study 
was aimed to recognize the effect of P. pentosaceus supplementation on stool frequency, tumor necrosis factor-α 
(TNF-α) and gut microflora balance in experimental mice with EPEC-induced diarrhea. 
Method: The study was conducted in 60 white mice (Mus muscullus) at Biomedical Laboratory, Biotechnology/
Production and Animal Husbandry Technology Institute, University of Andalas, Padang in April 2012. 
The frequency of stool, TNF-α level and microflora balance of the mice were measured before and after 
the EPEC-induced diarrhea and following the administration of antibiotics. Statistical analysis was performed 
using ANOVA and Duncan test. 
Results: The highest mean stool frequency was found in positive control group, i.e. 55 times, which was 
reduced significantly after 12-hour P. pentosaceus supplementation in a dose of 2 x 108 cfu/g into 18 times. 
The mean TNF-α level in positive control group was 128.17 pg/mL that lowered significantly to 48.0 pg/mL. 
The highest mean total number of LAB was 97.0 x 107 cfu/g, which was significantly different from positive 
control group of 7 x 107 cfu/g.
Conclusion: P. pentosaceus supplementation in a dose of 2 x 108 cfu/g may reduce the stool frequency, lower 
TNF-α and improve the gut microflora balance following 12-hour supplementation in diarrhea-induced mice. 
Keywords: Pediococcus pentosaceus, TNF-α, diarrhea, EPEC, gut microflora 
ABSTRAK 
Latar belakang: Enteropathogenic Escherichia coli (EPEC) merupakan kuman patogen yang dapat 
menyebabkan inflamasi dan ketidakseimbangan mikroflora usus sehingga menyebabkan diare. Pediococcus 
pentosaceus (P. pentosaceus) pada isolasi “dadih” sebagai probiotik mengandung bakteri asam laktat (BAL) 
yang bermanfaat dalam memperbaiki keseimbangan mikroflora intestinal dan menghambat pertumbuhan mikroba 
patogen. Penelitian ini bertujuan untuk mengetahui pengaruh dosis dan lamanya pemberian P. pentosaceus 
terhadap frekuensi buang air besar (BAB), kadar total necrosis factor- α (TNF-α) dan keseimbangan mikroflora 
usus mencit diare yang diinduksi EPEC.
Metode: Penelitian dilakukan pada 60 mencit putih (Mus muscullus) di Laboratorium Biomedik, Bioteknologi/
Produksi dan Teknologi Peternakan, Universitas Andalas Padang pada bulan April 2012. Dilakukan pengukuran 
frekuensi BAB, pemeriksaan kadar TNF-α, keseimbangan mikroflora usus mencit sebelum dan setelah pemberian 
EPEC, serta setelah pemberian probiotik. Analisis statistik dilakukan dengan uji ANOVA dan Duncan. 
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Hasil: Rata-rata frekuensi BAB terbanyak pada kelompok kontrol positif sebanyak 55 kali dan berkurang 
sangat nyata setelah 12 jam pemberian P. pentosaceus dengan dosis 2 x 108 cfu/g menjadi 18 kali. Rata-rata 
kadar TNF-α pada kontrol positif sebesar 128,17 pg/mL, menurun sangat nyata setelah 12 jam pemberian 
P. pentosaceus menjadi 48,0 pg/mL. Rerata kadar total kuman BAL tertinggi pada pemberian P. pentosaceus 
dosis 2 x 108 cfu/g yaitu 97,0 x 107 cfu/g dan berbeda sangat nyata dengan kelompok kontrol positif yaitu 
7 x 107 cfu/g.
Simpulan: Pemberian P. pentosaceus dengan dosis 2 x 108 cfu/g setelah 12 jam dapat menurunkan frekuensi 
BAB, menghambat kadar TNF-α serta memperbaiki keseimbangan mikroflora usus pada mencit diare.
Kata kunci: Pediococcus pentosaceus, TNF-α, diare, EPEC, mikroflora usus
INTRODUCTION 
As one of contagious diseases, diarrhea is 
the third leading cause of death following tuberculosis 
(TB) and pneumonia.1 The most common causes 
of diarrhea are viruses and bacteria including 
the enteropathogenic Escherichia coli (EPEC). 
Attachment of EPEC to the intestinal mucosa may 
lead to alteration of cell structure, which subsequently 
invades into the intestinal epithelial cells and when 
being consumed in a dose of 108 cfu/mL, EPEC may 
cause diarrhea.2,3
Tumor necrosis factor-α (TNF-α) are the main 
cytokines in acute inflammatory response against 
negative gram bacteria and other microorganisms.4 
High TNF-α serum level may damage the tight 
junction in the enterocytes of intestinal mucosa.5 
The cumulative effect of intestinal atrophy and 
damaged tight junction causes increased membrane 
permeability which results in disrupted intestinal 
absorption leading to diarrhea. Changes in normal 
human gut microbiota may cause various intestinal 
disorders and diseases; however, in normal condition 
the microbiota may prevent overgrowth of pathogenic 
bacteria in gastrointestinal tract.5,6 The balance of 
intestinal microflora will be achieved when beneficial 
microorganism may suppress the bad bacteria by 
causing the pathogenic microorganisms petered out.7 
Probiotics are living bacteria given as food supplement 
that may bring beneficial effect to human health by 
enhancing the balance of intestinal microflora.8-10 
Probiotics may inhibit the production of pro-
inflammatory cytokines.11 Pena et al, demonstrated that 
in lipopolysaccharide (LPS)-induced mice following 
Lactobacillus rhamnosus GG (LGG) supplementation, 
there is an inhibition of TNF-α production, which will 
affect tissue damage and cell apoptosis.12
Milk curd or “dadih” is a traditional dish of Western 
Sumatera containing lactic acid bacteria (LAB), 
which are useful to enhance human gastrointestinal 
tract function by inhibiting the growth of pathogenic 
microorganisms; while, the side product, nisin, are 
natural antibiotics to neutralize pathogenic gastro-
intestinal bacteria.13,14 
One of probiotic microorganism or the lactic 
acid bacteria that have been successfully isolated 
from the “milk curd” is Pediococcus pentosaceus 
(P. pentosaceus).15 Purwati found that P. pentosaceus, 
the LAB, could produce bacteriocins that can kill 
pathogenic microorganisms such as Lactobacillus 
monocytogenesis ,  Bifidobacterium subtillis, 
Streptococcus aureus, Escheria coli (E. coli) and 
Salmonella thypii.15 The aim of this study was to  
identify the effect of beneficial dosing and treatment 
period of P. pentosaceus supplementation on the 
frequency of stool, TNF-α level and the balance of 
intestinal microflora in mice with EPEC-induced 
diarrhea. 
METHOD 
An experimental study with complete random 
design using the factor pattern of 5 x 4, which was 
repeated for two times, was conducted in April 2012 
at Biomedical Laboratory, Biotechnology/Production 
and Animal Husbandry Technology Institute, 
University of Andalas, Padang. The sample were 
male  white mice (Mus musculus) obtained from the 
study and development unit of experimental animal 
pharmaceutical laboratory in University of Andalas, 
Padang. There were 60 mice used at eight weeks of 
age and weighing 25-30 g. 
The experimental animals were randomly catego- 
rized into two factors. The first factor was the dose, 
which included a negative control group receiving 
only standard pellet feed and plain water (C-); 
other three positive control groups with pellet 
feed containing EPEC in a dose of 108 cfu/g (C+), 
isolates of P. pentosaceus obtained from the ”milk 
curd” at dose of 2 x 108 cfu/g, 2 x 109 cfu/g, and 
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2 x 1010 cfu/g, respectively. The second factor was 
the duration of treatment, i.e. 0 hour, 12 hours, 
24 hours and 36 hours. 
In the first week, the mice were acclimated or 
went through adaptation process. During this period, 
60 mice were given standard pellet feed and 
water ad libitum. When the adaptation period had 
been completed, we selected the mice weighing 
approximately 27 g randomly and categorized them 
according to the abovementioned groups. There were 
three mice in each repeated unit. Before providing 
the EPEC, all mice in the negative control group 
were measured for their frequency of stools, TNF-α 
level and the balance of their gut microflora at 0 hour. 
Afterward, similar measurements were performed for 
the positive control group that had been adjusted with 
their duration of treatment. 
Analysis of variance or ANOVA was used to 
evaluate the effect of treatment and the interaction on 
the observed variables. When the treatment had been 
proven to have any effect, we continued the analysis 
by using the Duncan’s multiple range test. Statistical 
analysis and data management were carried out using 
SPSS 19. 
RESULTS 
The statistical analysis of Duncan’s multiple range 
test showed that there was a very obvious interaction 
(p < 0.01) between the dose factor and duration of 
treatment factor on the frequency of stool (the amount 
of stool) and TNF-α level (Table 1 and 2). 
Table 1 shows the mean value of stool frequency 
after 12-hour EPEC administration in positive control 
group. The most frequent was 55 times, which 
indicated 10 fold increase compared to the normal 
group that only have 5 times. 
After the first 12 hours of Pediococcus supplemen-
tation in a dose of 2 x 108 cfu/g, there was an obvious 
reduction in stool frequency from approximately 
18 times to 3 times. 
Table 2 demonstrates the very obvious increase 
(p < 0.01) of TNF-α level following the 12-hour EPEC 
administration, i.e. mean value of 128.17 pg/mL, 
which was 10 times compared to the control group 
without treatment of 12.31 pg/mL. The TNF-α level 
lowered almost three fold after 12-hour P. pentosaceus 
supplementation in a dose of 2 x 108 cfu/g into 
48.0 pg/mL.
The total number of LAB colony increased 
significantly after 12-hours P. pentosaceus 
supplementation in dose of 2 x 108, i.e. 97.0 x 107 
cfu/g that indicate almost 24 fold increase compared 
to both negative and positive control group. The lowest 
mean value was found in positive control group after 
24 hours of EPEC supplementation, i.e. 1.0 x 107 cfu/g 
(Table 3).
Table 1. The mean value of stool frequency in mice with various 
treatment
Dose factor 
(cfu/g)
Duration of treatment (hour)
Total
0 12 24 36 
C (-) 4.5h 5.5h 5.5h 5.0h 20.5
C (+) 6.0h 54.5a 36.0b 36.5b 133.0
2 x 108 5.5h 17.5e 16.5e 16.0e 60.5
2 x 109 4.5h 28.5d 25.5d 12.5f 71.0
2 x 1010 4.5h 31.0c 14.5e 11.5g 61.5
Total 25.0 137.0 98.0 86.5 346.5
Standard deviation (SD): 1.26; C (-): negative control; C (+): positive control; 
different alphabet shows significantly difference; Duncan’s multiple range test
Table 2. The mean value of TNF-α level (pg/mL) in the stool of 
mice with various treatment
Dose factor
(cfu/g)
Duration of treatment (hour)
Total
0 12 24 36 
C (-) 13.27l 12.31l 12.23l 12.29l 50.10
C (+) 13.33l 128.17a 123.19b 87.05c 351.74
2 x 108 12.30l 48.00f 42.10g 25.04j 127.44
2 x 109 12.30l 56.91d 37.65h 17.84k 124.70
2 x 1010 11.29l 65.93d 41.81g 39.86i 158.90
Total 62.49 311.32 256.98 182.08 812.88
SD: 0.46; C (-): negative control; C (+): positive control; different alphabet 
shows significantly difference (p < 0.01); Duncan’s multiple range test
Table 3. The mean value of total LAB colony (x 107 cfu/g) in 
the mice gut with several treatment
Dose factor
(cfu/g)
Duration of treatment (hour)
Total
0 12 24 36 
C (-) 3.5h 4.0h 5.5h 4.5h 7.5
C (+) 4.0h 6.5h 0.5i 5.5h 16.5
2 x 108 5.0h 97.0a 43.0f 61.5c 206.5
2 x 109 2.5h 84.0b 60.5c 20.5g 167.5
2 x 1010 6.0h 48.0e 53.5d 22.0g 129.5
Total 21.5 239.5 163.0 114.0 537.5
SD: 0.83; C (-): negative control; C (+): positive control; different alphabet
shows significantly difference (p < 0.01); Duncan’s multiple range test
The highest mean value of total aerobic microorganism 
colony in the positive control group after 36 hours of 
EPEC supplementation was 33.0 x 107 cfu/g, which 
showed 2.4 fold increase compared to the negative 
control group of 14.0 x 107 cfu/g. The mean value of 
total aerobic microorganism colony was found reduced 
after 12-hour P. pentosaceus supplementation in a dose 
of 2 x 108 cfu/g, which was 5.0 (Table 4).
Based on the result of Duncan’s multiple range 
test, we found a very obvious interaction (p < 0.01) 
between the dose and duration of treatment regarding 
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the total number of intestinal E. coli colony with 
the highest mean value in positive control group after 
12 hours of EPEC administration of 19.0 x 107 cfu/g. 
It indicated three-fold increase compared to the normal 
value of 7.0 x 107 cfu/g. The lowest mean value of 
total E. coli colony was found in the group receiving 
P. pentosaceus supplementation in a dose of 2 x 108 
cfu/g and obvious decrease was observed (p < 0.01) 
after 12-hours P. pentosaceus supplementation with 
mean value of 3.0 (Table 5). 
even to improve diarrhea into normal condition. 
P. pentosaceus supplementation with different dosing 
regimen in this study has demonstrated reduced stool 
frequency compared to the condition following EPEC 
administration. This study is supported by the results of 
study conducted by Saavedra.17 The study found varied 
doses of probiotics in several other studies that ranged 
between 107 and 1010 cfu daily depending on the method 
being used; however, the most common dose is about 
108–1010 cfu/day.17
This study also found increased TNF-α level that 
may reach 10 fold of normal limit. It suggests that in 
EPEC-induced mice, there is inflammatory process 
characterized by increased TNF-α level. The results 
of this study are consistent with Lapointe’s statement 
that inflammatory responses are associated with EPEC 
microorganisms that infect intestinal mucosa. It may 
cause increased proinflammatory cytokines, such as 
TNF-α, interferon gamma, and IL-1β.18 In this study, 
we found that three dose regimens might reduce 
inflammation as indicated by reduced TNF-α level. 
This findings are also supported by Galdeano et al who 
suggest that the recommended dose to bring additional 
effect for immune response or on the mucosa ranges 
between 1 x 108 and 1 x 109 cfu/day, which is also 
effective when given in 48-72 hours.19 
This study results are also consistent with the 
study conducted by Pena and Versalovici, which 
demonstrated that LGG may specifically inhibited 
TNF-α against apoptosis or cytotoxic effect.12 
The secretion of TNF-α occurs after 5 hours of LPS 
supplementation in mice, which was measured using 
quantitative ELISA. The LGG ability to inhibit LPS that 
produce TNF-α may also depend on LPS concentration, 
which will be reduced with increased LPS concentration. 
Another study that consistent with this study is 
the study conducted by Kusuma et al showing that 
supplementation of Lactobacillus strain LIS10506 or 
LIS20506 would inhibit the NFkB activation. Although 
the mechanism is not clear, but it has significantly 
reduced TNFR1 expression (as an equivalent of TNF-α 
activity).20
There was also increased total number of LAB 
microorganisms following probiotics supplementation. 
Such condition suggests that P. pentosaceus of milk curd 
may overcome various barriers in the gastrointestinal 
tract such as low pH (in the stomach). Increased total 
LAB colony may also indicate that P. pentosaceus are 
able to compete with pathogenic microorganisms. This 
study is consistent with the study conducted by Heriyenni 
that LAB produces bacteriocin, the extracell of LAB 
Table 4. The mean value of total aerobic microorganism colony 
in the mice gut with several treatment
Dose factor
(cfu/g)
Duration of treatment (hour)
Total
0 12 24 36
C (-) 12.0e 12.5e 11.5e 14.0b 50.0
C (+) 12.0e 7.5b 32.0a 32.5a 84.0
2 x 108 10.5e 4.5g 5.5g 3.5g 24.0
2 x 109 8.0e 14.0c 9.0f 5.0b 36.0
2 x 1010 8.0e 10.0d 10.0d 4.0g 32.0
Total 50.5 39.5. 73.0 63.0 226.0
SD:  0.81; C (-): negative control; C (+): positive control; different alphabet 
shows significantly difference (p < 0.01); Duncan’s multiple range test
Table 5. The mean value of Eschericia coli colony in the mice 
gut with several treatment
Dose
(cfu/g)
Duration of treatment (hour)
Total
0 12 24 36
C (-) 6.5d 7.0d 7.5d 6.5d 27.5
C (+) 5.5d 19.0b 21.5a 11.0c 57.0
2 x 108 7.5d 2.5e 1.5e 3.5e 15.0
2  x 109 5.5d 5.0d 2.5e 2.5e 15.5
2 x 1010 6.5d 7.0d 4.5e 2.5e 20.5
Total 31.50 40.5 37.5 26.0 135.5
SD: 0.62; C (-): negative control; C (+): positive control; different 
alphabet shows significantly difference (p < 0.01); Duncan’s multiple range test
DISCUSSION 
EPEC are pathogenic microorganisms that can 
penetrate intestinal mucosa and invade enterocytes, 
which may result in diarrhea. The diarrhea was 
observed in this study as the greater stool frequency in 
mice compared to the negative control group without 
administration of EPEC. The healthy mice (without 
EPEC infection) did not experience diarrhea, which 
could be evaluated by measuring the number of stool 
in mice. The results of this study is consistent with the 
study conducted by Liu et al, which demonstrated that 
the LPS-induced mice (E. coli serotype 0128) have 
experienced diarrhea compared to those without LPS (p 
< 0.01) and the diarrhea was improved after probiotics 
supplementation.16 
This study demonstrated that Pediococcus are 
the probiotics that can compete with EPEC in the 
gastrointestinal tract to reduce stool frequency or 
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with antimicrobial effect.21 The WHO also supported this 
study results stating that the attachment ability of LAB on 
the bowel is an important factor that must be owned by 
probiotics.22 Another study that in agreement with this 
study is the study conducted by Arief et al. It showed 
that there was significantly higher total number of 
LAB attached to caecum mucosa following probiotics 
supplementation in EPEC-induced mice (p < 0.01).23 
The mean value of total aerobic in this study 
increased in positive control group (EPEC-induced) 
and reduced after Pediococcus supplementation. 
The results of this study shows that Pediococcus obtained 
from the milk curd may inhibit E. coli population and 
kill pathogenic microorganism in intestinal mucosa. 
The findings are supported by Adolffson et al, who 
suggested that Lactobacillus sp originated from the 
milk curd can overcome invasion of pathogenic bacteria 
in the intestines.24 The suggestion is also supported by 
Surono, who stated that  milk curd contains LAB that 
may exert the function of killing pathogenic bacteria in 
the intestines.13 
The results of this study are consistent with 
the results of study conducted by Arief et al who 
investigate total number of E. coli in caecum mucosa 
of EPEC-induced mice. They found that by the 
second week, there was significantly lower total 
EPEC colony (p < 0.05) in EPEC-induced mice that 
had been supplemented with L. plantarum 2C12 and 
L. acidophilus 2B4 probiotics compared to those EPEC-
infected mice without supplementation.23 The results 
of this study are also corroborated by Asaduzzaman & 
Sonomoto, who suggests that bacteriocins can inhibit 
the growth of other microorganism by developing cavity 
or pore at the sensitive cell membrane or cell wall and 
lowering the potential or pH gradient which causes 
cellular damage leading to cell lysis.25 
The limitation of this study is the short treatment 
period, i.e. 36 hours; hence, the expected effect has 
not reached its maximal potency. Further studies 
should provide longer observation period to investigate 
the optimal effect of probiotics as has been suggested by 
Galdeano et al, that probicotics is effective when being 
used for 48-72 hours.19 Longer duration of probiotic 
treatment has also been investigated by Kusuma et al, 
who evaluated LPS-induced mice with 7-day probiotics 
treatment which has anti-inflammatory effect.20
CONCLUSION 
The 12-hour Pediococcus pentosaceus supplementation 
in a dose of 2 x 108 cfu/g may reduce stool frequency, 
lower TNF-α level and improve the balance of gut 
microflora in EPEC-induced diarrhea mice. 
SUGGESTION 
Further studies are needed to evaluate Pediococcus 
pentosaceus supplementation in children with diarrhea.
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